On the public citation graph

Prevention of Acute Exacerbations of COPD

0 signed · 564 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/archinte.159.2.156openalex-snapshot

For COPD a Combination of Ipratropium Bromide and Albuterol Sulfate Is More Effective Than Albuterol Base

inferredcites →https://doi.org/10.1001/archinte.163.5.585openalex-snapshot

Reduction of Hospital Utilization in Patients With Chronic Obstructive Pulmonary Disease A Disease-Specific Self-management Intervention

inferredcites →https://doi.org/10.1001/archneur.63.12.1686openalex-snapshot

Clinical and Demographic Predictors of Long-term Disability in Patients With Relapsing-Remitting Multiple Sclerosis

inferredcites →https://doi.org/10.1001/jama.1994.03520190043033openalex-snapshot

Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1

inferredcites →https://doi.org/10.1001/jama.272.19.1497openalex-snapshot

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study

inferredcites →https://doi.org/10.1001/jama.288.14.1775openalex-snapshot

Improving Primary Care for Patients With Chronic Illness

inferredcites →https://doi.org/10.1001/jama.288.15.1909openalex-snapshot

Improving Primary Care for Patients With Chronic Illness

inferredcites →https://doi.org/10.1002/14651858.cd001390.pub2openalex-snapshot

Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd001390.pub3openalex-snapshot

Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd002733.pub2openalex-snapshot

Influenza vaccine for patients with chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd002990.pub2openalex-snapshot

Self-management education for patients with chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd002990.pub3openalex-snapshot

Self management for patients with chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd002991.pub3openalex-snapshot

Inhaled corticosteroids for stable chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd002999openalex-snapshot

Smoking cessation for chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd003793.pub2openalex-snapshot

Pulmonary rehabilitation for chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd003793.pub3openalex-snapshot

Pulmonary rehabilitation for chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd005305.pub3openalex-snapshot

Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd005305.pub4openalex-snapshot

Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd006101openalex-snapshot

Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd006826.pub2openalex-snapshot

Combined corticosteroid and long-acting beta2 -agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd006829openalex-snapshot

Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd006829.pub2openalex-snapshot

Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus long-acting beta 2 -agonists for chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd007033openalex-snapshot

Inhaled corticosteroids versus long acting beta-agonists for chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd007033.pub3openalex-snapshot

Inhaled corticosteroids versus long-acting beta2-agonists for chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd007718.pub2openalex-snapshot

Telehealthcare for chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd009157openalex-snapshot

Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd009157.pub2openalex-snapshot

Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd009285.pub2openalex-snapshot

Tiotropium versus placebo for chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd009285.pub3openalex-snapshot

Tiotropium versus placebo for chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd009437openalex-snapshot

Integrated disease management interventions for patients with chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd009437.pub2openalex-snapshot

Integrated disease management interventions for patients with chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd009552openalex-snapshot

Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd009552.pub3openalex-snapshot

Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd010177openalex-snapshot

Long-acting beta2-agonists for chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd010177.pub2openalex-snapshot

Long-acting beta2-agonists for chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1002/14651858.cd010384openalex-snapshot

Non-pharmacological management interventions for COPD: an overview of Cochrane systematic reviews

inferredcites →https://doi.org/10.1002/chp.47openalex-snapshot

Lost in knowledge translation: Time for a map?

inferredcites →https://doi.org/10.1007/bf00606554openalex-snapshot

A controlled trial of intermittent oral acetylcysteine in the long-term treatment of chronic bronchitis

inferredcites →https://doi.org/10.1007/s00408-011-9289-0openalex-snapshot

Inappropriate Overuse of Inhaled Corticosteroids for COPD Patients: Impact on Health Costs and Health Status

inferredcites →https://doi.org/10.1007/s00408-013-9487-zopenalex-snapshot

Clinical Outcomes and Cost Analysis of Exacerbations in Chronic Obstructive Pulmonary Disease

inferredcites →https://doi.org/10.1007/s11096-011-9585-zopenalex-snapshot

Impact of pharmaceutical care on health outcomes in patients with COPD

inferredcites →https://doi.org/10.1007/s11606-007-0118-3openalex-snapshot

Impact of Pneumococcal Vaccination on Pneumonia Rates in Patients with COPD and Asthma

inferredcites →https://doi.org/10.1007/s11606-009-0907-yopenalex-snapshot

The Effects of Smoking Cessation on the Risk of Chronic Obstructive Pulmonary Disease Exacerbations

inferredcites →https://doi.org/10.1016/0002-9343(86)90468-7openalex-snapshot

Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease: A 90-day multi-center study

inferredcites →https://doi.org/10.1016/0002-9343(87)90556-0openalex-snapshot

Influenza: Quantifying morbidity and mortality

inferredcites →https://doi.org/10.1016/0007-0971(87)90182-3openalex-snapshot

Oral fabrol (oral N-acetylcysteine) in chronic bronchitis

inferredcites →https://doi.org/10.1016/j.amjmed.2012.06.024openalex-snapshot

Inflammation in COPD: Implications for Management

inferredcites →https://doi.org/10.1016/j.amjmed.2013.01.036openalex-snapshot

Statin Use and Risk of COPD Exacerbation Requiring Hospitalization

inferredcites →https://doi.org/10.1016/j.arbr.2012.03.005openalex-snapshot

The Excessive Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease

inferredcites →https://doi.org/10.1016/j.arbres.2012.01.002openalex-snapshot

Utilización excesiva de corticoides inhalados en la enfermedad pulmonar obstructiva crónica

inferredcites →https://doi.org/10.1016/j.bbrc.2011.02.035openalex-snapshot

Decreased histone deacetylase 2 impairs Nrf2 activation by oxidative stress

inferredcites →https://doi.org/10.1016/j.clinthera.2011.08.010openalex-snapshot

Statin Use and Hospitalization in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Cohort Study in Taiwan

inferredcites →https://doi.org/10.1016/j.clinthera.2012.06.005openalex-snapshot

Effect of Once-Daily Fluticasone Furoate/Vilanterol on 24-Hour Pulmonary Function in Patients With Chronic Obstructive Pulmonary Disease: A Randomized, Three-Way, Incomplete Block, Crossover Study

inferredcites →https://doi.org/10.1016/j.coph.2012.02.019openalex-snapshot

New bronchodilators

inferredcites →https://doi.org/10.1016/j.eurtel.2013.05.001openalex-snapshot

Comparing the costs of home telemonitoring and usual care of chronic obstructive pulmonary disease patients: A randomized controlled trial

inferredcites →https://doi.org/10.1016/j.ijmedinf.2012.06.003openalex-snapshot

A feasibility study to investigate the acceptability and potential effectiveness of a telecare service for older people with chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1016/j.jacc.2006.04.039openalex-snapshot

Reduction of Morbidity and Mortality by Statins, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin Receptor Blockers in Patients With Chronic Obstructive Pulmonary Disease

inferredcites →https://doi.org/10.1016/j.jamda.2013.03.003openalex-snapshot

Discharge Coordinator Intervention Prevents Hospitalizations in Patients With COPD: A Randomized Controlled Trial

inferredcites →https://doi.org/10.1016/j.jclinepi.2010.07.015openalex-snapshot

GRADE guidelines: 3. Rating the quality of evidence

inferredcites →https://doi.org/10.1016/j.pupt.2003.09.001openalex-snapshot

The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD

inferredcites →https://doi.org/10.1016/j.pupt.2006.09.001openalex-snapshot

Safety, tolerability and efficacy of indacaterol, a novel once-daily β2-agonist, in patients with COPD: A 28-day randomised, placebo controlled clinical trial

inferredcites →https://doi.org/10.1016/j.pupt.2010.01.003openalex-snapshot

Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless design

inferredcites →https://doi.org/10.1016/j.pupt.2010.03.003openalex-snapshot

The scientific rationale for combining long-acting β2-agonists and muscarinic antagonists in COPD

inferredcites →https://doi.org/10.1016/j.pupt.2010.08.006openalex-snapshot

Effects of inhaled corticosteroids in stable chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1016/j.pupt.2011.06.003openalex-snapshot

Statins and outcome after hospitalization for COPD exacerbation: A prospective study

inferredcites →https://doi.org/10.1016/j.pupt.2011.07.006openalex-snapshot

24-hour Bronchodilation following a single dose of the novel β2-agonist olodaterol in COPD

inferredcites →https://doi.org/10.1016/j.pupt.2011.10.006openalex-snapshot

Comparison of three combined pharmacological approaches with tiotropium monotherapy in stable moderate to severe COPD: A systematic review

inferredcites →https://doi.org/10.1016/j.pupt.2012.08.007openalex-snapshot

28-Day safety and tolerability of umeclidinium in combination with vilanterol in COPD: A randomized placebo-controlled trial

inferredcites →https://doi.org/10.1016/j.rmed.2004.03.017openalex-snapshot

Gender does not influence the response to the combination of salmeterol and fluticasone propionate in COPD

inferredcites →https://doi.org/10.1016/j.rmed.2005.02.033openalex-snapshot

Extending a home from hospital care programme for COPD exacerbations to include pulmonary rehabilitation

inferredcites →https://doi.org/10.1016/j.rmed.2006.10.012openalex-snapshot

Exacerbations and lung function decline in COPD: New insights in current and ex-smokers

inferredcites →https://doi.org/10.1016/j.rmed.2007.10.007openalex-snapshot

Efficacy and safety of formoterol fumarate delivered by nebulization to COPD patients

inferredcites →https://doi.org/10.1016/j.rmed.2007.10.010openalex-snapshot

The cost of moderate and severe COPD exacerbations to the Canadian healthcare system

inferredcites →https://doi.org/10.1016/j.rmed.2008.04.019openalex-snapshot

Effect of fluticasone propionate/salmeterol (250/50 μg) or salmeterol (50 μg) on COPD exacerbations

inferredcites →https://doi.org/10.1016/j.rmed.2008.10.026openalex-snapshot

Airflow obstruction and exercise

inferredcites →https://doi.org/10.1016/j.rmed.2008.11.003openalex-snapshot

Fluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitis

inferredcites →https://doi.org/10.1016/j.rmed.2010.11.019openalex-snapshot

Aclidinium bromide improves exercise endurance and lung hyperinflation in patients with moderate to severe COPD

inferredcites →https://doi.org/10.1016/j.rmed.2011.02.013openalex-snapshot

Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD

inferredcites →https://doi.org/10.1016/j.rmed.2011.07.020openalex-snapshot

Effect of budesonide/formoterol pMDI on COPD exacerbations: A double-blind, randomized study

inferredcites →https://doi.org/10.1016/j.rmed.2012.12.014openalex-snapshot

A randomised trial of fluticasone furoate/vilanterol (50/25 μg; 100/25 μg) on lung function in COPD

inferredcites →https://doi.org/10.1016/j.rmed.2012.12.016openalex-snapshot

Fluticasone furoate/vilanterol (100/25; 200/25 μg) improves lung function in COPD: A randomised trial

inferredcites →https://doi.org/10.1016/j.rmed.2013.05.016openalex-snapshot

Safety and efficacy of dual bronchodilation with QVA149 in COPD patients: The ENLIGHTEN study

inferredcites →https://doi.org/10.1016/j.rmed.2013.06.001openalex-snapshot

Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD

inferredcites →https://doi.org/10.1016/j.rmedu.2007.02.003openalex-snapshot

Pulmonary rehabilitation in chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1016/j.tips.2011.04.003openalex-snapshot

Novel bronchodilators for the treatment of chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1016/j.vaccine.2008.05.037openalex-snapshot

Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease

inferredcites →https://doi.org/10.1016/s0002-9343(96)80037-4openalex-snapshot

Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1016/s0002-9343(96)80061-1openalex-snapshot

A multicenter study of nebulized bronchodilator solutions in chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1016/s0002-9343(96)80073-8openalex-snapshot

Addition of anticholinergic solution prolongs bronchodilator effect of β2agonists in patients with chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1016/s0002-9343(96)80109-4openalex-snapshot

Results of a multicenter study of nebulized inhalant bronchodilator solutions

inferredcites →https://doi.org/10.1016/s0002-9343(99)00056-xopenalex-snapshot

Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the lung health study

inferredcites →https://doi.org/10.1016/s0140-6736(00)04724-3openalex-snapshot

Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial

inferredcites →https://doi.org/10.1016/s0140-6736(03)12459-2openalex-snapshot

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

inferredcites →https://doi.org/10.1016/s0140-6736(05)66456-2openalex-snapshot

Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial

inferredcites →https://doi.org/10.1016/s0140-6736(08)60869-7openalex-snapshot

Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study

inferredcites →https://doi.org/10.1016/s0140-6736(09)61252-6openalex-snapshot

Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials

inferredcites →https://doi.org/10.1016/s0140-6736(09)61255-1openalex-snapshot

Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials

inferredcites →https://doi.org/10.1016/s0140-6736(61)91248-xopenalex-snapshot

PROPHYLACTIC USE OF INFLUENZA VACCINE IN PATIENTS WITH CHRONIC BRONCHITIS

inferredcites →https://doi.org/10.1016/s0140-6736(96)04201-8openalex-snapshot

Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1016/s0140-6736(98)11326-0openalex-snapshot

Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial

inferredcites →https://doi.org/10.1016/s0738-3991(03)00100-9openalex-snapshot

The effects of patient education in COPD in a 1-year follow-up randomised, controlled trial

inferredcites →https://doi.org/10.1016/s0954-6111(03)80020-3openalex-snapshot

Economic analysis of the confronting COPD survey: an overview of results

inferredcites →https://doi.org/10.1016/s0954-6111(03)80022-7openalex-snapshot

The burden of COPD in Canada: results from the confronting COPD survey

inferredcites →https://doi.org/10.1016/s0954-6111(05)80337-3openalex-snapshot

Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis

inferredcites →https://doi.org/10.1016/s0954-6111(06)80220-9openalex-snapshot

N-acetylcysteine by metered dose inhaler in thetreatment of chronic bronchitis: a multi-centre study

inferredcites →https://doi.org/10.1016/s1579-2129(06)60576-4openalex-snapshot

Effectiveness of a Specific Program for Patients With Chronic Obstructive Pulmonary Disease and Frequent Exacerbations

inferredcites →https://doi.org/10.1016/s1836-9553(13)70168-1openalex-snapshot

Telehealth reduces hospital admission rates in patients with COPD

inferredcites →https://doi.org/10.1016/s2213-2600(12)70052-8openalex-snapshot

Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol–fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study

inferredcites →https://doi.org/10.1016/s2213-2600(13)70040-7openalex-snapshot

Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials

inferredcites →https://doi.org/10.1016/s2213-2600(13)70052-3openalex-snapshot

Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study

inferredcites →https://doi.org/10.1016/s2213-2600(13)70286-8openalex-snapshot

Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial

inferredcites →https://doi.org/10.1037/e548312006-001openalex-snapshot

Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

inferredcites →https://doi.org/10.1053/rmed.2000.0949openalex-snapshot

Home-based exercise is capable of preserving hospital-based improvements in severe chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1053/rmed.2002.1455openalex-snapshot

Bronchodilator effect of an inhaled combination therapy with salmeterol + fluticasone and formoterol + budesonide in patients with COPD

inferredcites →https://doi.org/10.1055/s-0035-1555610openalex-snapshot

Smoking Cessation in Chronic Obstructive Pulmonary Disease

inferredcites →https://doi.org/10.1056/nejm199906243402502openalex-snapshot

Effect of Systemic Glucocorticoids on Exacerbations of Chronic Obstructive Pulmonary Disease

inferredcites →https://doi.org/10.1056/nejmc1314411openalex-snapshot

Tiotropium and the Risk of Death in COPD

inferredcites →https://doi.org/10.1056/nejmoa012561openalex-snapshot

New Strains of Bacteria and Exacerbations of Chronic Obstructive Pulmonary Disease

inferredcites →https://doi.org/10.1056/nejmoa023161openalex-snapshot

Outpatient Oral Prednisone after Emergency Treatment of Chronic Obstructive Pulmonary Disease

inferredcites →https://doi.org/10.1056/nejmoa063070openalex-snapshot

Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease

inferredcites →https://doi.org/10.1056/nejmoa0805800openalex-snapshot

A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease

inferredcites →https://doi.org/10.1056/nejmoa1008378openalex-snapshot

Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD

inferredcites →https://doi.org/10.1056/nejmoa1104623openalex-snapshot

Azithromycin for Prevention of Exacerbations of COPD

inferredcites →https://doi.org/10.1056/nejmoa1303342openalex-snapshot

Tiotropium Respimat Inhaler and the Risk of Death in COPD

inferredcites →https://doi.org/10.1056/nejmoa1403086openalex-snapshot

Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD

inferredcites →https://doi.org/10.1080/15412550903140881openalex-snapshot

Effect of Fluticasone Propionate/Salmeterol (250/50) on COPD Exacerbations and Impact on Patient Outcomes

inferredcites →https://doi.org/10.1089/tmj.2011.0231openalex-snapshot

Pilot Study of Remote Telemonitoring in COPD

inferredcites →https://doi.org/10.1089/tmj.2011.0250openalex-snapshot

Cost-Utility Analysis of a Telerehabilitation Program: A Case Study of COPD Patients

inferredcites →https://doi.org/10.1093/cid/cis513openalex-snapshot

Long-term Comparative Immunogenicity of Protein Conjugate and Free Polysaccharide Pneumococcal Vaccines in Chronic Obstructive Pulmonary Disease

inferredcites →https://doi.org/10.1093/eurpub/ckr084openalex-snapshot

When are complex interventions 'complex'? When are simple interventions 'simple'?

inferredcites →https://doi.org/10.1093/geront/gnr134openalex-snapshot

Outcomes of a Telehealth Intervention for Homebound Older Adults With Heart or Chronic Respiratory Failure: A Randomized Controlled Trial

inferredcites →https://doi.org/10.1093/ntr/ntr263openalex-snapshot

Cost-effectiveness of an Intensive Smoking Cessation Intervention for COPD Outpatients

inferredcites →https://doi.org/10.1097/00008483-200511000-00012openalex-snapshot

Managing Chronic Obstructive Pulmonary Disease in the Community

inferredcites →https://doi.org/10.1097/hcr.0b013e3181c9c985openalex-snapshot

Long-term Effects of 1-Year Maintenance Training on Physical Functioning and Health Status in Patients With COPD

inferredcites →https://doi.org/10.1109/titb.2005.863877openalex-snapshot

Telemedicine Experience for Chronic Care in COPD

inferredcites →https://doi.org/10.1111/j.1365-2125.2009.03493.xopenalex-snapshot

Clinical pharmacy‐led disease and medicine management programme for patients with COPD

inferredcites →https://doi.org/10.1111/j.1365-2648.2004.03280.xopenalex-snapshot

Effects of nurse‐initiated telephone follow‐up on self‐efficacy among patients with chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1111/j.1440-1843.2006.00892.xopenalex-snapshot

Self‐management plans in the primary care of patients with chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1111/j.1440-1843.2006.00897.xopenalex-snapshot

Positive benefits of theophylline in a randomized, double‐blind, parallel‐group, placebo‐controlled study of low‐dose, slow‐release theophylline in the treatment of COPD for 1 year

inferredcites →https://doi.org/10.1111/j.1440-1843.2006.00902.xopenalex-snapshot

Written action plans in chronic obstructive pulmonary disease increase appropriate treatment for acute exacerbations

inferredcites →https://doi.org/10.1111/j.1440-1843.2008.01418.xopenalex-snapshot

Does early pulmonary rehabilitation reduce acute health‐care utilization in COPD patients admitted with an exacerbation? A randomized controlled study

inferredcites →https://doi.org/10.1111/j.1440-1843.2010.01921.xopenalex-snapshot

Effect of early pulmonary rehabilitation on health care utilization and health status in patients hospitalized with acute exacerbations of COPD

inferredcites →https://doi.org/10.1111/j.1440-1843.2011.02038.xopenalex-snapshot

Roflumilast in Asian patients with COPD: A randomized placebo‐controlled trial

inferredcites →https://doi.org/10.1111/j.1445-5994.1999.tb01621.xopenalex-snapshot

The effect of a respiratory home nurse intervention in patients with chronic obstructive pulmonary disease (COPD)

inferredcites →https://doi.org/10.1111/j.1445-5994.2004.00672.xopenalex-snapshot

A chronic disease management programme can reduce days in hospital for patients with chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1111/j.1447-0594.2011.00696.xopenalex-snapshot

Efficient integrated education for older patients with chronic obstructive pulmonary disease using the Lung Information Needs Questionnaire

inferredcites →https://doi.org/10.1111/j.1476-5381.2010.01199.xopenalex-snapshot

Glucocorticosteroids: current and future directions

inferredcites →https://doi.org/10.1111/j.1476-5381.2011.01216.xopenalex-snapshot

β2‐adrenoceptor agonists: current and future direction

inferredcites →https://doi.org/10.1111/j.1742-1241.1985.tb07868.xopenalex-snapshot

Long‐Term Oral Carbocisteine Therapy in Patients with Chronic Bronchitis. A Double Blind Trial with Placebo Control

inferredcites →https://doi.org/10.1111/j.1742-1241.2008.01731.xopenalex-snapshot

Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study

inferredcites →https://doi.org/10.1111/j.1752-699x.2008.00055.xopenalex-snapshot

The effectiveness of smoking cessation groups offered to hospitalised patients with symptoms of exacerbations of chronic obstructive pulmonary disease (COPD)

inferredcites →https://doi.org/10.1111/j.1752-699x.2010.00187.xopenalex-snapshot

Nurse tele‐consultations with discharged COPD patients reduce early readmissions – an interventional study

inferredcites →https://doi.org/10.1124/jpet.111.179259openalex-snapshot

Functional and Biochemical Rationales for the 24-Hour-Long Duration of Action of Olodaterol

inferredcites →https://doi.org/10.1128/iai.72.2.818-823.2004openalex-snapshot

Host-Pathogen Interaction during Pneumococcal Infection in Patients with Chronic Obstructive Pulmonary Disease

inferredcites →https://doi.org/10.1136/bmj.1.6077.1645openalex-snapshot

The natural history of chronic airflow obstruction.

inferredcites →https://doi.org/10.1136/bmj.320.7245.1297openalex-snapshot

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

inferredcites →https://doi.org/10.1136/bmj.325.7370.938openalex-snapshot

Randomised controlled trial of home based care of patients with chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1136/bmj.38258.662720.3aopenalex-snapshot

Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study

inferredcites →https://doi.org/10.1136/bmj.a1655openalex-snapshot

Developing and evaluating complex interventions: the new Medical Research Council guidance

inferredcites →https://doi.org/10.1136/bmj.d3215openalex-snapshot

Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials

inferredcites →https://doi.org/10.1136/bmj.e3874openalex-snapshot

Effect of telehealth on use of secondary care and mortality: findings from the Whole System Demonstrator cluster randomised trial

inferredcites →https://doi.org/10.1136/bmj.e7642openalex-snapshot

Comprehensive self management and routine monitoring in chronic obstructive pulmonary disease patients in general practice: randomised controlled trial

inferredcites →https://doi.org/10.1136/bmj.f1035openalex-snapshot

Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial

inferredcites →https://doi.org/10.1136/bmjopen-2011-000370openalex-snapshot

Efficacy and safety of 4 weeks' treatment with combined fluticasone furoate/vilanterol in a single inhaler given once daily in COPD: a placebo-controlled randomised trial

inferredcites →https://doi.org/10.1136/bmjopen-2013-003097openalex-snapshot

Effects of telephone health mentoring in community-recruited chronic obstructive pulmonary disease on self-management capacity, quality of life and psychological morbidity: a randomised controlled trial

inferredcites →https://doi.org/10.1136/bmjqs-2013-002293.184openalex-snapshot

P154 Development of the Documentation And Appraisal Review Tool (Dart) For Systematic Reviews

inferredcites →https://doi.org/10.1136/jech.52.6.377openalex-snapshot

The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions.

inferredcites →https://doi.org/10.1136/thorax.55.4.289openalex-snapshot

A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1136/thorax.57.11.967openalex-snapshot

Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study

inferredcites →https://doi.org/10.1136/thorax.57.9.759openalex-snapshot

Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations

inferredcites →https://doi.org/10.1136/thoraxjnl-2011-200071openalex-snapshot

Effect of an action plan with ongoing support by a case manager on exacerbation-related outcome in patients with COPD: a multicentre randomised controlled trial

inferredcites →https://doi.org/10.1136/thx.2005.052233openalex-snapshot

Complete response to erlotinib treatment in brain metastases from recurrent NSCLC

inferredcites →https://doi.org/10.1136/thx.2005.brusascolettopenalex-snapshot

Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD

inferredcites →https://doi.org/10.1136/thx.2006.063271openalex-snapshot

Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis

inferredcites →https://doi.org/10.1136/thx.2007.082636openalex-snapshot

Counting, analysing and reporting exacerbations of COPD in randomised controlled trials

inferredcites →https://doi.org/10.1136/thx.2009.124164openalex-snapshot

Outpatient pulmonary rehabilitation following acute exacerbations of COPD

inferredcites →https://doi.org/10.1136/thx.2010.139113openalex-snapshot

QVA149 demonstrates superior bronchodilation compared with indacaterol or placebo in patients with chronic obstructive pulmonary disease

inferredcites →https://doi.org/10.1136/thx.40.11.832openalex-snapshot

Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. British Thoracic Society Research Committee.

inferredcites →https://doi.org/10.1136/thx.54.1.7openalex-snapshot

Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis

inferredcites →https://doi.org/10.1146/annurev.physiol.010908.163257openalex-snapshot

Role of HDAC2 in the Pathophysiology of COPD

inferredcites →https://doi.org/10.1155/2007/161652openalex-snapshot

Treatment Persistence and Compliance with Medications for Chronic Obstructive Pulmonary Disease

inferredcites →https://doi.org/10.1155/2007/830570openalex-snapshot

Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2007 Update

inferredcites →https://doi.org/10.1155/2008/641965openalex-snapshot

Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2008 Update – Highlights for Primary Care

inferredcites →https://doi.org/10.1155/2010/425975openalex-snapshot

Optimizing Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease – Practical Issues: A Canadian Thoracic Society Clinical Practice Guideline

inferredcites →https://doi.org/10.1157/13093392openalex-snapshot

Eficacia de un programa específico para pacientes con EPOC que presentan frecuentes agudizaciones

inferredcites →https://doi.org/10.1159/000029295openalex-snapshot

Inhalation by Nebulization of Albuterol-Ipratropium Combination (Dey Combination) Is Superior to Either Agent Alone in the Treatment of Chronic Obstructive Pulmonary Disease

inferredcites →https://doi.org/10.1159/000029447openalex-snapshot

N-Acetylcysteine Reduces the Exacerbation Rate in Patients with Moderate to Severe COPD

inferredcites →https://doi.org/10.1159/000195871openalex-snapshot

Long-Lasting Effects on Rheology and Clearance of Bronchial Mucus after Short-Term Administration of High Doses of Carbocysteine-Lysine to Patients with Chronic Bronchitis

inferredcites →https://doi.org/10.1159/000196540openalex-snapshot

Prevention of Acute Exacerbations of Chronic Obstructive Bronchitis with Carbocysteine Lysine Salt Monohydrate: A Multicenter, Double-Blind, Placebo-Controlled Trial

inferredcites →https://doi.org/10.1159/000315416openalex-snapshot

Inhaled Corticosteroids in COPD: A Controversy

inferredcites →https://doi.org/10.1159/000316368openalex-snapshot

New Therapies for Chronic Obstructive Pulmonary Disease

inferredcites →https://doi.org/10.1159/000321374openalex-snapshot

Effect of 6 Months of Erythromycin Treatment on Inflammatory Cells in Induced Sputum and Exacerbations in Chronic Obstructive Pulmonary Disease

inferredcites →https://doi.org/10.1159/000350831openalex-snapshot

Fit Yourself and Take Your Lungs to Heart

inferredcites →https://doi.org/10.1161/circulationaha.106.177322openalex-snapshot

A Taxonomy for Disease Management

inferredcites →https://doi.org/10.1164/ajrccm.154.2.8756814openalex-snapshot

Controlled Trial of Oral Prednisone in Outpatients With Acute COPD Exacerbation

inferredcites →https://doi.org/10.1164/ajrccm.154.4.8887592openalex-snapshot

Outcomes Following Acute Exacerbation of Severe Chronic Obstructive Lung Disease. The SUPPORT Investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)

inferredcites →https://doi.org/10.1164/ajrccm.157.5.9709032openalex-snapshot

Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease

inferredcites →https://doi.org/10.1164/ajrccm.161.2.9901044openalex-snapshot

Smoking Cessation and Lung Function in Mild-to-Moderate Chronic Obstructive Pulmonary Disease: The Lung Health Study

inferredcites →https://doi.org/10.1164/ajrccm.162.1.9909066openalex-snapshot

Withdrawal of Chronic Systemic Corticosteroids in Patients with COPD

inferredcites →https://doi.org/10.1164/ajrccm.164.5.2012122openalex-snapshot

Dynamic Hyperinflation and Exercise Intolerance in Chronic Obstructive Pulmonary Disease

showing the first 200 of 282

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3863358openalex-extracted

A Benefit-Harm Analysis of Azithromycin for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

inferred← citeshttps://doi.org/10.1001/jama.2018.14295openalex-snapshot

Failure of Low-Dose Theophylline to Prevent Exacerbations in Patients With COPD

inferred← citeshttps://doi.org/10.1001/jama.2020.4437openalex-snapshot

Association Between Initiation of Pulmonary Rehabilitation After Hospitalization for COPD and 1-Year Survival Among Medicare Beneficiaries

inferred← citeshttps://doi.org/10.1001/jamainternmed.2018.7529openalex-snapshot

Factors Associated With High-Quality Guidelines for the Pharmacologic Management of Chronic Diseases in Primary Care

inferred← citeshttps://doi.org/10.1002/14651858.cd011594openalex-snapshot

Combined aclidinium bromide and long-acting beta 2 -agonist for COPD

inferred← citeshttps://doi.org/10.1002/14651858.cd011594.pub2openalex-snapshot

Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD)

inferred← citeshttps://doi.org/10.1002/14651858.cd011897openalex-snapshot

Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD)

inferred← citeshttps://doi.org/10.1002/14651858.cd011897.pub2openalex-snapshot

Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD)

inferred← citeshttps://doi.org/10.1002/14651858.cd015153openalex-snapshot

Non-pharmacological interventions for the prevention of hospitalisations in stable chronic obstructive pulmonary disease: component network meta-analysis

inferred← citeshttps://doi.org/10.1002/jcla.23823openalex-snapshot

Expression of long non‐coding RNA LUCAT1 in patients with chronic obstructive pulmonary disease and its potential functions in regulating cigarette smoke extract‐induced 16HBE cell proliferation and apoptosis

inferred← citeshttps://doi.org/10.1002/jhm.2334openalex-snapshot

Hospital management of acute exacerbations of chronic obstructive pulmonary disease

inferred← citeshttps://doi.org/10.1007/978-3-030-01782-8_55-1openalex-snapshot

Pulmonary Disease

inferred← citeshttps://doi.org/10.1007/978-3-030-64050-7_9openalex-snapshot

Ambulatory Telemedicine: Home-Based COPD Management

inferred← citeshttps://doi.org/10.1007/978-3-030-64739-1_20openalex-snapshot

Anesthetic Considerations in Candidates for Lung Volume Reduction Surgery (LVRS)

inferred← citeshttps://doi.org/10.1007/978-3-030-74720-6_55openalex-snapshot

Pulmonary Disease

inferred← citeshttps://doi.org/10.1007/978-981-10-0839-9_9openalex-snapshot

Exercise Therapy for COPD: How Is Exercise Therapy Significant?

inferred← citeshttps://doi.org/10.1007/s00408-019-00208-5openalex-snapshot

The Economic Effect of Early Management in Patients with Early Chronic Obstructive Pulmonary Disease: Results from a Population-Based Nationwide Survey

inferred← citeshttps://doi.org/10.1007/s13670-018-0253-1openalex-snapshot

Tailoring Treatment in Obstructive Lung Disease: Asthma, COPD, Asthma/COPD Overlap and Eosinophilic COPD

inferred← citeshttps://doi.org/10.1007/s40265-015-0450-6openalex-snapshot

Escalation and De-escalation of Therapy in COPD: Myths, Realities and Perspectives

inferred← citeshttps://doi.org/10.1007/s40271-019-00386-7openalex-snapshot

COPD-Specific Self-Management Support Provided by Trained Educators in Everyday Practice is Associated with Improved Quality of Life, Health-Directed Behaviors, and Skill and Technique Acquisition: A Convergent Embedded Mixed-Methods Study

inferred← citeshttps://doi.org/10.1007/s41030-016-0024-0openalex-snapshot

Indacaterol/Glycopyrronium Combination for COPD

inferred← citeshttps://doi.org/10.1007/s41030-017-0046-2openalex-snapshot

Improving the Efficiency of Respiratory Drug Delivery: A Review of Current Treatment Trends and Future Strategies for Asthma and Chronic Obstructive Pulmonary Disease

inferred← citeshttps://doi.org/10.1016/b978-0-08-102723-3.00041-xopenalex-snapshot

Overview of Current Management of COPD

inferred← citeshttps://doi.org/10.1016/j.amjmed.2015.07.032openalex-snapshot

Azithromycin for the Prevention of COPD Exacerbations: The Good, Bad, and Ugly

inferred← citeshttps://doi.org/10.1016/j.amjmed.2017.12.018openalex-snapshot

The Role of Fixed-Dose Dual Bronchodilator Therapy in Treating COPD

inferred← citeshttps://doi.org/10.1016/j.amjmed.2018.05.003openalex-snapshot

Chronic Obstructive Pulmonary Disease Exacerbations: A Need for Action

inferred← citeshttps://doi.org/10.1016/j.amjms.2016.06.006openalex-snapshot

Preventing Hospitalizations From Acute Exacerbations of Chronic Obstructive Pulmonary Disease

inferred← citeshttps://doi.org/10.1016/j.annepidem.2023.12.003openalex-snapshot

Non-adherence to COPD medications and its association with adverse events: A longitudinal population based cohort study of older adults

inferred← citeshttps://doi.org/10.1016/j.apnr.2021.151522openalex-snapshot

Early symptom recognition and symptom management among exacerbation COPD patients: A qualitative study

inferred← citeshttps://doi.org/10.1016/j.arbr.2016.05.020openalex-snapshot

Frequent or Persistent Exacerbations: Identifying the Real Problem

inferred← citeshttps://doi.org/10.1016/j.arbr.2021.10.018openalex-snapshot

GesEPOC 2021 and GOLD 2021. Closer together or further apart?

inferred← citeshttps://doi.org/10.1016/j.arbres.2016.05.019openalex-snapshot

Agudizaciones frecuentes o persistentes: identificando el problema real

inferred← citeshttps://doi.org/10.1016/j.arbres.2021.04.009openalex-snapshot

GesEPOC 2021 y GOLD 2021. ¿Más cerca o más lejos?

inferred← citeshttps://doi.org/10.1016/j.arbres.2021.04.030openalex-snapshot

[Translated article] GesEPOC 2021 and GOLD 2021. Closer together or further apart?

inferred← citeshttps://doi.org/10.1016/j.cct.2025.107961openalex-snapshot

Protocol for a pragmatic trial to enhance quality safety, and patient experience in chronic obstructive pulmonary disease (EQuiP-COPD)

inferred← citeshttps://doi.org/10.1016/j.cdtm.2018.07.002openalex-snapshot

Fine particulate matter (PM 2.5 ): The culprit for chronic lung diseases in China

inferred← citeshttps://doi.org/10.1016/j.chest.2015.11.011openalex-snapshot

Spread the Word About CHEST in 2016

inferred← citeshttps://doi.org/10.1016/j.chest.2016.05.002openalex-snapshot

COPD Readmissions

inferred← citeshttps://doi.org/10.1016/j.chest.2017.04.156openalex-snapshot

Statins in COPD

inferred← citeshttps://doi.org/10.1016/j.chest.2018.12.018openalex-snapshot

Which Physicians Are Taking Care of People With COPD?

inferred← citeshttps://doi.org/10.1016/j.chest.2019.04.131openalex-snapshot

Effects of Clinical Pathways for COPD on Patient, Professional, and Systems Outcomes

inferred← citeshttps://doi.org/10.1016/j.chest.2019.06.005openalex-snapshot

Reducing COPD Readmissions

inferred← citeshttps://doi.org/10.1016/j.chest.2019.11.044openalex-snapshot

A Geographic Analysis of Racial Disparities in Use of Pulmonary Rehabilitation After Hospitalization for COPD Exacerbation

inferred← citeshttps://doi.org/10.1016/j.chest.2020.02.045openalex-snapshot

Minimal Clinically Important Differences for Patient-Reported Outcome Measures of Fatigue in Patients With COPD Following Pulmonary Rehabilitation

inferred← citeshttps://doi.org/10.1016/j.chest.2021.05.067openalex-snapshot

Factors Associated With Nonreceipt of Recommended COPD Medications

inferred← citeshttps://doi.org/10.1016/j.chest.2022.03.047openalex-snapshot

Optimizing COPD Acute Care Patient Outcomes Using a Standardized Transition Bundle and Care Coordinator

inferred← citeshttps://doi.org/10.1016/j.emc.2015.08.002openalex-snapshot

Management of Acute Exacerbation of Asthma and Chronic Obstructive Pulmonary Disease in the Emergency Department

inferred← citeshttps://doi.org/10.1016/j.emc.2022.05.007openalex-snapshot

Evaluation and Management of Asthma and Chronic Obstructive Pulmonary Disease Exacerbation in the Emergency Department

inferred← citeshttps://doi.org/10.1016/j.iac.2023.05.002openalex-snapshot

Non-Pharmacological Treatments of Asthma Chronic Obstructive Pulmonary Disease Overlap and Rehabilitation Programs

inferred← citeshttps://doi.org/10.1016/j.jcjq.2021.03.007openalex-snapshot

A Practice Redesign Collaborative for Reducing Hospital Readmission for Chronic Obstructive Pulmonary Disease in an Affiliated Network of Health Care Organizations

inferred← citeshttps://doi.org/10.1016/j.jphys.2017.11.004openalex-snapshot

In chronic obstructive pulmonary disease, home-based maintenance telerehabilitation reduced the risk of exacerbations, hospitalisations and emergency visits [commentary]

inferred← citeshttps://doi.org/10.1016/j.mayocp.2017.03.020openalex-snapshot

Chronic Obstructive Pulmonary Disease Phenotypes: Implications for Care

inferred← citeshttps://doi.org/10.1016/j.mayocp.2018.05.026openalex-snapshot

COPD Guidelines: A Review of the 2018 GOLD Report

inferred← citeshttps://doi.org/10.1016/j.mcna.2020.02.003openalex-snapshot

Recent Advances in the Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

inferred← citeshttps://doi.org/10.1016/j.pccm.2025.11.004openalex-snapshot

Type 2 inflammation in chronic obstructive pulmonary disease: A promising treatable trait and practice recommendations

inferred← citeshttps://doi.org/10.1016/j.pharmthera.2016.06.013openalex-snapshot

Emerging therapies for the treatment of skeletal muscle wasting in chronic obstructive pulmonary disease

inferred← citeshttps://doi.org/10.1016/j.pulmoe.2018.03.006openalex-snapshot

Symptoms irregularity and increased risk of COPD acute exacerbations

inferred← citeshttps://doi.org/10.1016/j.rce.2019.03.006openalex-snapshot

Consenso para el manejo de pacientes con EPOC según el índice CODEX

inferred← citeshttps://doi.org/10.1016/j.rceng.2019.03.022openalex-snapshot

Consensus for managing patients with chronic obstructive pulmonary disease according to the CODEX index

inferred← citeshttps://doi.org/10.1016/j.resmer.2023.100995openalex-snapshot

Dysbiosis and leaky gut in hyper-inflated COPD patients: Have smoking and exercise training any role?

inferred← citeshttps://doi.org/10.1016/j.rmed.2016.02.002openalex-snapshot

Adverse events among COPD patients treated with long-acting anticholinergics and β2-agonists in an outpatient respiratory clinic

inferred← citeshttps://doi.org/10.1016/j.rmed.2016.10.013openalex-snapshot

A randomized, controlled multicentric study of inhaled budesonide and intravenous methylprednisolone in the treatment on acute exacerbation of chronic obstructive pulmonary disease

inferred← citeshttps://doi.org/10.1016/j.rmed.2016.12.015openalex-snapshot

Evaluating the risk of pneumonia with inhaled corticosteroids in COPD: Retrospective database studies have their limitations SA

inferred← citeshttps://doi.org/10.1016/j.rmed.2018.08.001openalex-snapshot

Trends in the utilisation of COPD therapeutic regimens before and after the introduction of LAMA/LABA combination products: A population-based study

inferred← citeshttps://doi.org/10.1016/j.rmed.2020.106085openalex-snapshot

Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Kong during coronavirus disease 2019 pandemic

inferred← citeshttps://doi.org/10.1016/j.rmr.2017.03.010openalex-snapshot

Quel doit être le suivi à distance ?

inferred← citeshttps://doi.org/10.1016/j.rmr.2017.03.012openalex-snapshot

Quelle est la place de l’éducation thérapeutique dans la prévention des exacerbations ?

inferred← citeshttps://doi.org/10.1016/j.rppnen.2015.08.008openalex-snapshot

COPD: Evidence-based medicine or the patient-centered medicine?

inferred← citeshttps://doi.org/10.1016/j.rppnen.2015.10.006openalex-snapshot

COPD: Are we using all the tools we have?

inferred← citeshttps://doi.org/10.1016/j.rppnen.2016.02.009openalex-snapshot

COPD and physical activity

inferred← citeshttps://doi.org/10.1016/j.semarthrit.2019.11.010openalex-snapshot

Risk of exacerbation of pulmonary comorbidities in patients with rheumatoid arthritis after initiation of abatacept versus TNF inhibitors: A cohort study

inferred← citeshttps://doi.org/10.1016/j.synres.2018.05.001openalex-snapshot

Regulation of monocyte redox balance by 1,8-cineole (eucalyptol) controls oxidative stress and pro-inflammatory responses in vitro: A new option to increase the antioxidant effects of combined respiratory therapy with budesonide and formoterol?

inferred← citeshttps://doi.org/10.1016/j.whi.2020.05.003openalex-snapshot

Lifetime History of Sexual Assault and Emergency Department Service Use among Women Veterans

inferred← citeshttps://doi.org/10.1016/s0140-6736(22)01273-9openalex-snapshot

Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission

inferred← citeshttps://doi.org/10.1016/s2213-2600(16)00094-1openalex-snapshot

Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective

inferred← citeshttps://doi.org/10.1038/npjpcrm.2015.23openalex-snapshot

Four patients with a history of acute exacerbations of COPD: implementing the CHEST/Canadian Thoracic Society guidelines for preventing exacerbations

inferred← citeshttps://doi.org/10.1038/npjpcrm.2016.68openalex-snapshot

Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawal

inferred← citeshttps://doi.org/10.1038/s41533-017-0028-8openalex-snapshot

Hospital readmissions for COPD: a retrospective longitudinal study

inferred← citeshttps://doi.org/10.1038/s41533-018-0079-5openalex-snapshot

'Exacerbation-free time' to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD): a prospective observational study

inferred← citeshttps://doi.org/10.1038/s41533-019-0119-9openalex-snapshot

The impact of integrated disease management in high-risk COPD patients in primary care

inferred← citeshttps://doi.org/10.1038/s41533-026-00549-8openalex-snapshot

Global perceptions and practices on systemic corticosteroid use for asthma and COPD in primary care: results from a multinational survey on prescribers and community pharmacists

inferred← citeshttps://doi.org/10.1038/s41598-020-79555-wopenalex-snapshot

Modulation of cAMP metabolism for CFTR potentiation in human airway epithelial cells

inferred← citeshttps://doi.org/10.1055/a-0620-1002openalex-snapshot

Expertentreffen COPD: Integriertes Patientenmanagement bei COPD

inferred← citeshttps://doi.org/10.1055/a-2818-1414openalex-snapshot

Epidemiology of COPD Exacerbations

inferred← citeshttps://doi.org/10.1055/a-2837-8778openalex-snapshot

Role of Vaccination in the Prevention of ECOPD

inferred← citeshttps://doi.org/10.1056/nejmra1900500openalex-snapshot

Update on Clinical Aspects of Chronic Obstructive Pulmonary Disease

inferred← citeshttps://doi.org/10.1080/00015385.2025.2577557openalex-snapshot

Hospitalisations during the 30-day period preceding admissions with cardiac arrest

inferred← citeshttps://doi.org/10.1080/00325481.2017.1353885openalex-snapshot

Individualizing the selection of long-acting bronchodilator therapy for patients with COPD: considerations in primary care

inferred← citeshttps://doi.org/10.1080/07853890.2024.2396567openalex-snapshot

Methodology for the selection and evaluation of outcomes for Chinese herbal injection in acute exacerbation of chronic obstructive pulmonary disease (AECOPD): a comprehensive study

inferred← citeshttps://doi.org/10.1080/14656566.2017.1328497openalex-snapshot

An update on the pharmacotherapeutic management of lower respiratory tract infections

inferred← citeshttps://doi.org/10.1080/15412555.2017.1347918openalex-snapshot

Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis

inferred← citeshttps://doi.org/10.1080/15412555.2018.1543390openalex-snapshot

Quality of Care Delivered to Veterans with COPD Exacerbation and the Association with 30-Day Readmission and Death

inferred← citeshttps://doi.org/10.1080/15412555.2019.1682535openalex-snapshot

Phase II Study of Single/Repeated Doses of Acumapimod (BCT197) to Treat Acute Exacerbations of COPD

inferred← citeshttps://doi.org/10.1080/17460441.2016.1184642openalex-snapshot

The discovery of roflumilast for the treatment of chronic obstructive pulmonary disease

inferred← citeshttps://doi.org/10.1080/17476348.2018.1417041openalex-snapshot

Multidimensional approach for the proper management of a complex chronic patient with chronic obstructive pulmonary disease

inferred← citeshttps://doi.org/10.1080/17476348.2019.1601559openalex-snapshot

Pharmacogenomics of chronic obstructive pulmonary disease

inferred← citeshttps://doi.org/10.1080/17476348.2026.2659383openalex-snapshot

Respiratory health in a changing environment: environment-adaptive therapies and revised dosing strategies

inferred← citeshttps://doi.org/10.1080/21548331.2016.1224007openalex-snapshot

Malnutrition screening in patients admitted to hospital with an exacerbation of chronic obstructive pulmonary disease and its association with patient outcomes

inferred← citeshttps://doi.org/10.1080/24745332.2017.1395588openalex-snapshot

CTS position statement: Pharmacotherapy in patients with COPD—An update

inferred← citeshttps://doi.org/10.1080/24745332.2019.1668652openalex-snapshot

Canadian Thoracic Society Clinical Practice Guideline on pharmacotherapy in patients with COPD – 2019 update of evidence

inferred← citeshttps://doi.org/10.1080/24745332.2020.1743212openalex-snapshot

Enhancing pulmonary rehabilitation enrollment study (PRESS III)

inferred← citeshttps://doi.org/10.1080/24745332.2020.1747033openalex-snapshot

Canadian consensus recommendations for a research agenda in pulmonary rehabilitation post-acute exacerbation of COPD: A meeting report

inferred← citeshttps://doi.org/10.1080/24745332.2023.2298539openalex-snapshot

Rapid access rehabilitation after exacerbations of chronic obstructive pulmonary disease: A Delphi study

inferred← citeshttps://doi.org/10.1080/24745332.2024.2357798openalex-snapshot

Lung function and symptom recovery in chronic obstructive pulmonary disease with pneumonic and non-pneumonic exacerbations

inferred← citeshttps://doi.org/10.1089/tmj.2022.0050openalex-snapshot

Effectiveness of a Home-Based Pulmonary Rehabilitation Program in Veterans

inferred← citeshttps://doi.org/10.1093/ajhp/zxaa216openalex-snapshot

Emerging role of pharmacists in managing patients with chronic obstructive pulmonary disease

inferred← citeshttps://doi.org/10.1093/annalsats/aaoag184openalex-snapshot

Population health management in chronic obstructive pulmonary disease: an official American Thoracic Society Workshop Report

inferred← citeshttps://doi.org/10.1097/01.jaa.0000000000000377openalex-snapshot

COPD

inferred← citeshttps://doi.org/10.1097/cnq.0000000000000341openalex-snapshot

Acute Exacerbation of Chronic Obstructive Pulmonary Disease

inferred← citeshttps://doi.org/10.1097/hcr.0000000000000735openalex-snapshot

Strategies to Improve Enrollment and Participation in Pulmonary Rehabilitation Following a Hospitalization for COPD

inferred← citeshttps://doi.org/10.1097/mcp.0000000000000246openalex-snapshot

Biomass smoke exposure and chronic lung disease

inferred← citeshttps://doi.org/10.1097/mcp.0000000000000460openalex-snapshot

Self-management strategies in chronic obstructive pulmonary disease

inferred← citeshttps://doi.org/10.1097/mcp.0000000000000551openalex-snapshot

The role of statins in chronic obstructive pulmonary disease

inferred← citeshttps://doi.org/10.1097/mcp.0000000000001242openalex-snapshot

Chronic obstructive pulmonary disease exacerbations for the academic hospitalist: an opportunity to learn and improve care

inferred← citeshttps://doi.org/10.1097/md.0000000000021856openalex-snapshot

A comparison of the efficacy and safety of combined aclidinium bromide and formoterol fumarate in the treatment of chronic obstructive pulmonary disease

inferred← citeshttps://doi.org/10.1097/md.0000000000025672openalex-snapshot

Evaluation of the curative effects of Bailing capsules for treating chronic obstructive pulmonary disease

inferred← citeshttps://doi.org/10.1097/md.0000000000027324openalex-snapshot

Efficacy and safety of traditional Chinese medicine injections in the treatment of chronic obstructive pulmonary disease

inferred← citeshttps://doi.org/10.1097/md.0000000000044589openalex-snapshot

Association of systemic immune-inflammation index and aggregate index of systemic inflammation with clinical status in stable and exacerbated COPD: A single-center retrospective study

inferred← citeshttps://doi.org/10.1109/enbeng.2017.7889481openalex-snapshot

OneCare Spiro: Mobile application for monitoring and pre-diagnosis of Chronic Obstructive Pulmonary Disease

inferred← citeshttps://doi.org/10.1111/crj.12507openalex-snapshot

The effect of pulmonary rehabilitation on COPD exacerbation frequency per year

inferred← citeshttps://doi.org/10.1111/imj.13594openalex-snapshot

High rates of respiratory symptoms and airway disease in mental health inpatients in a tertiary centre

inferred← citeshttps://doi.org/10.1111/jocn.14814openalex-snapshot

Acute exacerbations of chronic obstructive pulmonary disease (COPD) experiences among COPD patients with comorbid gastrooesophageal reflux disease

inferred← citeshttps://doi.org/10.1111/resp.12780openalex-snapshot

Acute exacerbation of COPD

inferred← citeshttps://doi.org/10.1124/pr.119.018150openalex-snapshot

Pharmacology and Therapeutics of Bronchodilators Revisited

inferred← citeshttps://doi.org/10.1136/bmjopen-2025-103891openalex-snapshot

Non-invasive neuromodulation for alleviating dyspnoea: protocol for a feasibility sham-controlled randomised trial

inferred← citeshttps://doi.org/10.1136/bmjresp-2017-000265openalex-snapshot

Development of a patient-centred, evidence-based and consensus-based discharge care bundle for patients with acute exacerbation of chronic obstructive pulmonary disease

inferred← citeshttps://doi.org/10.1136/bmjresp-2018-000379openalex-snapshot

Innovating the treatment of COPD exacerbations: a phone interactive telesystem to increase COPD Action Plan adherence

inferred← citeshttps://doi.org/10.1136/bmjresp-2023-002101openalex-snapshot

Rate of severe exacerbations, healthcare resource utilisation and clinical outcomes in patients with COPD in low-income and middle-income countries: results from the EXACOS International Study

inferred← citeshttps://doi.org/10.1136/thorax-2023-221211openalex-snapshot

Quantifying sustained health system benefits of primary care-based integrated disease management for COPD: a 6-year interrupted time series study

inferred← citeshttps://doi.org/10.1136/thoraxjnl-2021-217962openalex-snapshot

Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease

inferred← citeshttps://doi.org/10.1142/s0192415x17500148openalex-snapshot

The Use of Chinese Herbal Medicine in the Treatment of Chronic Obstructive Pulmonary Disease (COPD)

inferred← citeshttps://doi.org/10.1155/2015/932857openalex-snapshot

Respiratory Medicine in Saskatchewan: An Historical Perspective

inferred← citeshttps://doi.org/10.1155/2016/4173962openalex-snapshot

Effects of Low-Dose and Long-Term Treatment with Erythromycin on Interleukin-17 and Interleukin-23 in Peripheral Blood and Induced Sputum in Patients with Stable Chronic Obstructive Pulmonary Disease

inferred← citeshttps://doi.org/10.1155/2019/5952742openalex-snapshot

The Effects of Safflower Yellow on Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Randomized, Controlled Clinical Trial

inferred← citeshttps://doi.org/10.1159/000439228openalex-snapshot

Vasoactive Intestinal Peptide for Diagnosing Exacerbation in Chronic Obstructive Pulmonary Disease

inferred← citeshttps://doi.org/10.1159/000495256openalex-snapshot

Let’s Call It Lung Shock – Or Do We Use the Right Wording?

inferred← citeshttps://doi.org/10.1164/rccm.201510-1966stopenalex-snapshot

An Official American Thoracic Society/European Respiratory Society Policy Statement: Enhancing Implementation, Use, and Delivery of Pulmonary Rehabilitation

inferred← citeshttps://doi.org/10.1164/rccm.202003-0705edopenalex-snapshot

Increasing Pulmonary Rehabilitation Uptake after Hospitalization for Chronic Obstructive Pulmonary Disease Exacerbation. Let’s Rise to the Challenge

inferred← citeshttps://doi.org/10.1164/rccm.202107-1768edopenalex-snapshot

Pulmonary Rehabilitation after a Chronic Obstructive Pulmonary Disease Exacerbation: Impact on Readmission Risk in a Real-World Setting

inferred← citeshttps://doi.org/10.1177/00185787261465850openalex-snapshot

Predicting Disease Severity and Mortality Using a Simple Clinical Risk Score (ABCDMP) in Patients with AECOPD in the UAE

inferred← citeshttps://doi.org/10.1177/0300060518788751openalex-snapshot

The role of argyrophilic nucleolar organizing region-associated proteins in clinical exacerbation of chronic obstructive pulmonary disease

inferred← citeshttps://doi.org/10.1177/0898264319895842openalex-snapshot

Utilization of Medications With Cognitive Impairment Side Effects and the Implications for Older Adults’ Cognitive Function

inferred← citeshttps://doi.org/10.1177/1357633x20970402openalex-snapshot

Effects of post-discharge telemonitoring on 30-day chronic obstructive pulmonary disease readmissions and mortality

inferred← citeshttps://doi.org/10.1177/1479972316633414openalex-snapshot

Rural and remote care

inferred← citeshttps://doi.org/10.1177/1479972317723237openalex-snapshot

The Quebec Respiratory Health Education Network: Integrating a model of self-management education in COPD primary care

inferred← citeshttps://doi.org/10.1177/1479972317724570openalex-snapshot

Telehealth pulmonary rehabilitation: A review of the literature and an example of a nationwide initiative to improve the accessibility of pulmonary rehabilitation

inferred← citeshttps://doi.org/10.1177/1479973119895457openalex-snapshot

Models of care across the continuum of exacerbations for patients with chronic obstructive pulmonary disease

inferred← citeshttps://doi.org/10.1177/14799731231179105openalex-snapshot

Implementation and maintenance of an enhanced pulmonary rehabilitation program in a single centre: An implementation study

inferred← citeshttps://doi.org/10.1177/1753465816630208openalex-snapshot

Inhaled corticosteroids and the increased risk of pneumonia: what’s new? A 2015 updated review

inferred← citeshttps://doi.org/10.1177/1753466620963021openalex-snapshot

Efficacy of FF/UMEC/VI compared with FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the Spain cohort in IMPACT

inferred← citeshttps://doi.org/10.1177/17534666261466906openalex-snapshot

Development and validation of a multimodal risk prediction model for early COPD progression: a retrospective study integrating clinical, functional, and CT radiomic features

inferred← citeshttps://doi.org/10.1183/13993003.00577-2017openalex-snapshot

Comparison of different staging methods for COPD in predicting outcomes

inferred← citeshttps://doi.org/10.1183/13993003.00851-2018openalex-snapshot

Making sense of telemedicine in the management of COPD

inferred← citeshttps://doi.org/10.1183/13993003.00907-2024openalex-snapshot

Residential exposure toAspergillusspp.is associated with exacerbations in COPD

inferred← citeshttps://doi.org/10.1183/16000617.0106-2017openalex-snapshot

Impact of the financial crisis on COPD burden: Greece as a case study

inferred← citeshttps://doi.org/10.1183/23120541.00252-2021openalex-snapshot

Multicentre comparison of self-management in patients with COPD

inferred← citeshttps://doi.org/10.1186/s12890-021-01692-3openalex-snapshot

Prediction of readmission in patients with acute exacerbation of chronic obstructive pulmonary disease within one year after treatment and discharge

inferred← citeshttps://doi.org/10.1186/s12890-024-03091-wopenalex-snapshot

Development and validation of a nomogram for assessing survival in acute exacerbation of chronic obstructive pulmonary disease patients

inferred← citeshttps://doi.org/10.1186/s12913-017-2750-xopenalex-snapshot

The development, implementation and evaluation of clinical pathways for chronic obstructive pulmonary disease (COPD) in Saskatchewan: protocol for an interrupted times series evaluation

inferred← citeshttps://doi.org/10.1186/s12913-020-5030-0openalex-snapshot

Healthcare utilization after a first hospitalization for COPD: a new approach of State Sequence Analysis based on the '6W' multidimensional model of care trajectories

inferred← citeshttps://doi.org/10.1186/s12931-017-0601-2openalex-snapshot

Optimizing bronchodilation in the prevention of COPD exacerbations

inferred← citeshttps://doi.org/10.1186/s12931-023-02393-7openalex-snapshot

Pulmonary rehabilitation after severe exacerbation of COPD: a nationwide population study

inferred← citeshttps://doi.org/10.1186/s12931-024-02704-6openalex-snapshot

A simple clinical risk score (ABCDMP) for predicting mortality in patients with AECOPD and cardiovascular diseases

inferred← citeshttps://doi.org/10.1186/s13063-016-1623-7openalex-snapshot

Effectiveness of a pharmacist-driven intervention in COPD (EPIC): study protocol for a randomized controlled trial

inferred← citeshttps://doi.org/10.1186/s13104-016-2105-4openalex-snapshot

A case report of QT prolongation with glycopyrronium bromide in a patient with chronic tamoxifen use

inferred← citeshttps://doi.org/10.1186/s13643-016-0311-8openalex-snapshot

Effects of clinical pathways for chronic obstructive pulmonary disease (COPD) on patient, professional and systems outcomes: protocol for a systematic review

inferred← citeshttps://doi.org/10.1186/s40248-016-0039-2openalex-snapshot

N-acetylcysteine in COPD: why, how, and when?

inferred← citeshttps://doi.org/10.1186/s40814-020-00705-yopenalex-snapshot

A feasibility pragmatic clinical trial of a primary care network exercise and education program for people with COPD

inferred← citeshttps://doi.org/10.12677/acm.2024.142595openalex-snapshot

Advances in Pulmonary Rehabilitation during Acute Exacerbations of Chronic Obstructive Pulmonary Disease

inferred← citeshttps://doi.org/10.12968/pnur.2016.27.6.276openalex-snapshot

Prevention and management of COPD exacerbations

inferred← citeshttps://doi.org/10.1371/journal.pone.0191404openalex-snapshot

Real-life effectiveness and safety of salbutamol Steri-Neb™ vs. Ventolin Nebules® for exacerbations in patients with COPD: Historical cohort study

inferred← citeshttps://doi.org/10.1371/journal.pone.0193610openalex-snapshot

Protective effects of tiotropium alone or combined with budesonide against cadmium inhalation induced acute neutrophilic pulmonary inflammation in rats

inferred← citeshttps://doi.org/10.1371/journal.pone.0340308openalex-snapshot

The investigation and prevalence of pulmonary embolism among emergency department patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD): A multi-centered linked administrative database study

inferred← citeshttps://doi.org/10.14198/jhse.2019.14.proc4.47openalex-snapshot

Efficiency physical rehabilitation patients with chronic obstructive pulmonary disease with moderate severity

inferred← citeshttps://doi.org/10.14201/gredos.137107openalex-snapshot

Prevención de exacerbaciones de las enfermedades respiratorias crónicas con la vacunación antineumocócica conjugada de 13 serotipos

inferred← citeshttps://doi.org/10.1513/annalsats.201601-060cmeopenalex-snapshot

ATS Core Curriculum 2016. Part IV. Adult Pulmonary Medicine Core Curriculum

inferred← citeshttps://doi.org/10.1513/annalsats.201704-308ocopenalex-snapshot

Home-based Physical Activity Coaching, Physical Activity, and Health Care Utilization in Chronic Obstructive Pulmonary Disease. Chronic Obstructive Pulmonary Disease Self-Management Activation Research Trial Secondary Outcomes

inferred← citeshttps://doi.org/10.1513/annalsats.201805-332ocopenalex-snapshot

Participation in Pulmonary Rehabilitation after Hospitalization for Chronic Obstructive Pulmonary Disease among Medicare Beneficiaries

inferred← citeshttps://doi.org/10.1513/annalsats.201812-854ocopenalex-snapshot

A Qualitative Study to Inform a More Acceptable Pulmonary Rehabilitation Program after Acute Exacerbation of Chronic Obstructive Pulmonary Disease

inferred← citeshttps://doi.org/10.1513/annalsats.202009-1160ocopenalex-snapshot

Evaluation of an Enhanced Pulmonary Rehabilitation Program: A Randomized Controlled Trial

inferred← citeshttps://doi.org/10.1513/annalsats.202304-301ocopenalex-snapshot

A Cost-Effectiveness Analysis of Azithromycin for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

inferred← citeshttps://doi.org/10.1513/annalsats.202402-196ocopenalex-snapshot

Use of Pulmonary Rehabilitation after Chronic Obstructive Pulmonary Disease Hospitalization: An Analysis of Statewide Patient and Hospital Data

inferred← citeshttps://doi.org/10.1517/14656566.2016.1155555openalex-snapshot

Treatment options for moderate-to-very severe chronic obstructive pulmonary disease

inferred← citeshttps://doi.org/10.15326/jcopdf.2020.0193openalex-snapshot

Pulmonary Rehabilitation and Readmission Rates for Medicare Beneficiaries with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

inferred← citeshttps://doi.org/10.15326/jcopdf.2021.0272openalex-snapshot

Waiting for Actionable Evidence: Roflumilast or Azithromycin?

inferred← citeshttps://doi.org/10.15326/jcopdf.5.4.2018.0133openalex-snapshot

Antioxidants and Chronic Obstructive Pulmonary Disease

inferred← citeshttps://doi.org/10.1586/17476348.2016.1121105openalex-snapshot

Oxidation pathway and exacerbations in COPD: the role of NAC

inferred← citeshttps://doi.org/10.1590/s1806-37562016000000287openalex-snapshot

Long-acting muscarinic antagonists vs. long-acting β 2 agonists in COPD exacerbations: a systematic review and meta-analysis

inferred← citeshttps://doi.org/10.18332/tid/85944openalex-snapshot

Tobacco Treatment Guideline for High Risk Groups: A pilot study in patients with Chronic Obstructive Pulmonary Disease

inferred← citeshttps://doi.org/10.21019/pharmacotherapyfirst.copd_overviewopenalex-snapshot

Chronic Obstructive Pulmonary Disease (COPD)

inferred← citeshttps://doi.org/10.21037/jtd.2017.03.116openalex-snapshot

Roles of roflumilast, a selective phosphodiesterase 4 inhibitor, in airway diseases

inferred← citeshttps://doi.org/10.21203/rs.3.rs-100937/v1openalex-snapshot

Implementation and Sustainability of an Enhanced Pulmonary Rehabilitation Program in a Single Centre

inferred← citeshttps://doi.org/10.21203/rs.3.rs-106900/v1openalex-snapshot

Implementation and Sustainability of an Enhanced Pulmonary Rehabilitation Program in a single centre

inferred← citeshttps://doi.org/10.2147/copd.s100401openalex-snapshot

COPD exacerbation care bundle improves standard of care, length of stay, and readmission rates

inferred← citeshttps://doi.org/10.2147/copd.s102570openalex-snapshot

Prompt initiation of maintenance treatment following a COPD exacerbation: outcomes in a large insured population

inferred← citeshttps://doi.org/10.2147/copd.s114423openalex-snapshot

Mucoactive and antioxidant medicines for COPD: consensus of a group of Chinese pulmonary physicians

inferred← citeshttps://doi.org/10.2147/copd.s138867openalex-snapshot

Self-management behaviors to reduce exacerbation impact in COPD patients: a Delphi study

inferred← citeshttps://doi.org/10.2147/copd.s139470openalex-snapshot

Impact and prevention of severe exacerbations of COPD: a review of the evidence

inferred← citeshttps://doi.org/10.2147/copd.s142378openalex-snapshot

Prediction models for exacerbations in different COPD patient populations: comparing results of five large data sources

inferred← citeshttps://doi.org/10.2147/copd.s157230openalex-snapshot

Risk factors for respiratory hospitalizations in a population of patients with a clinical diagnosis of COPD

showing the first 200 of 282

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.